Ferro-F-Tab was listed on the PBS after the deletion of FGF (ferrous sulfate 250 mg with folic acid 300 micrograms) on 1 April 2005. The Pharmaceutical Benefits Advisory Committee (PBAC) considered it appropriate that such a product be available for concessional status patients and Indigenous Australians.

Ferro-F-Tab is used to prevent and treat iron and folate deficiency, particularly during pregnancy and in megaloblastic anaemia. Do not start these tablets until vitamin B12 deficiency has been excluded — they do not prevent the neurological damage that B12 deficiency may cause.